Safety and Efficacy of Cenobamate for the Treatment of Focal Seizures in Older Patients: Post Hoc Analysis of a Phase III, Multicenter, Open-Label Study

被引：0
|
作者：
Rebecca O’Dwyer
Sean Stern
Clarence T. Wade
Anuradha Guggilam
William E. Rosenfeld
机构：
[1] Rush University Medical Center,Epilepsy Section, Department of Neurological Sciences, Comprehensive Epilepsy Clinic for Elderly
[2] SK Life Science,undefined
[3] Inc.,undefined
[4] Comprehensive Epilepsy Care Center for Children and Adults,undefined
来源：
Drugs & Aging | 2024年 / 41卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：251 / 260
页数：9
相关论文
共 50 条
  • [31] Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease
    Doody, RS
    Geldmacher, DS
    Gordon, B
    Perdomo, CA
    Pratt, RD
    ARCHIVES OF NEUROLOGY, 2001, 58 (03) : 427 - 433
  • [32] Efficacy and safety of lanadelumab in Japanese patients with hereditary angioedema: A phase 3 multicenter, open-label study
    Hide, Michihiro
    Ohsawa, Isao
    Nurse, Christina
    Yu, Ming
    JOURNAL OF DERMATOLOGY, 2023, 50 (11): : 1381 - 1391
  • [33] Efficacy and safety of secukinumab in patients with generalized pustular psoriasis: A 52-week analysis from phase III open-label multicenter Japanese study
    Imafuku, Shinichi
    Honma, Masaru
    Okubo, Yukari
    Komine, Mayumi
    Ohtsuki, Mamitaro
    Morita, Akimichi
    Seko, Noriko
    Kawashima, Naoko
    Ito, Saori
    Shima, Tomohiro
    Nakagawa, Hidemi
    JOURNAL OF DERMATOLOGY, 2016, 43 (09): : 1011 - 1017
  • [34] Efficacy And Safety Of Adjunctive Perampanel In Chinese Patients With Partial-Onset Seizures Or Primary Generalised Tonic-Clonic Seizures: Post Hoc Analysis Of Phase III Double-Blind And Open-Label Extension Studies
    Weiping, L.
    Dong, Z.
    Zhen, H.
    Patten, A.
    Dash, A.
    Malhotra, M.
    EPILEPSIA, 2019, 60 : 156 - 156
  • [35] AN OPEN-LABEL MULTICENTER STUDY OF GABAPENTIN MONOTHERAPY AND SAFETY IN MEDICALLY REFRACTORY PATIENTS WITH PARTIAL SEIZURES
    HAYES, A
    GREELEY, C
    HES, M
    MANN, M
    GAROFALO, E
    LEIDERMAN, D
    PIERCE, M
    NEUROLOGY, 1995, 45 (04) : A250 - A250
  • [36] Efficacy and safety of degarelix in Korean patients with prostate cancer requiring androgen deprivation therapy: Open-label multicenter phase III study
    You, Dalsan
    Chung, Byung Ha
    Lee, Sang Eun
    Kim, Choung-Soo
    PROSTATE INTERNATIONAL, 2015, 3 (01) : 22 - 26
  • [37] Number of seizure-free days with adjunctive cenobamate: post-hoc analysis of an open-label extension study
    Brandt, C.
    Fabo, D.
    Milovanovic, M.
    Alvarez-Baron, E.
    Thangavelu, K.
    Milanov, I.
    EPILEPSIA, 2023, 64 : 58 - 58
  • [38] Open-label multicenter study to assess efficacy and safety of prophylactic migraine treatment with topiramate
    Santos-Zambrano, J. A.
    Rodriguez-Leyva, I
    Salinas-Estebane, R.
    Fernandez Alvarado, B.
    Nunez-Orozco, L.
    REVISTA MEXICANA DE NEUROCIENCIA, 2005, 6 (01): : 38 - 41
  • [39] Number of seizure-free days with adjunctive cenobamate: post-hoc analysis of an open-label extension study
    Brandt, C.
    Fabo, D.
    Milovanovic, M.
    Alvarez-Baron, E.
    Thangavelu, K.
    Milanov, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 171 - 171
  • [40] Efficacy and safety of perampanel as early add-on therapy in Chinese patients with focal-onset seizures: a multicenter, open-label, single-arm study
    Gao, Lehong
    Lu, Qiang
    Wang, Zan
    Yue, Wei
    Wang, Guoping
    Shao, Xiaoqiu
    Guo, Yi
    Yi, Yonghong
    Hong, Zhen
    Jiang, Yuwu
    Xiao, Bo
    Cui, Guiyun
    Gao, Feng
    Hu, Jiasheng
    Liang, Jianmin
    Zhang, Meiyun
    Wang, Yuping
    FRONTIERS IN NEUROLOGY, 2023, 14
12345